ERBITUX
- Registry ID
- EUCTR2008-005013-21
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE2
- Sponsor
- Institut de Cancérologie de la Loire
- Start date
- 2009-01-23
- Last update
- 2026-08-16
Conditions
- Locally advanced non small cell lung cancer
Summary
To determine the feasibility in terms of toxicity of the association of cetuximab and concomitant radio-chemotherapy in each of both arms, in order to select the best arm of association.
Locations
View on source registry